Praxis Precision Medicines, Inc.
PRAX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001689548
No open-market purchases or sales by Praxis Precision Medicines, Inc. insiders were filed in the last 90 days; 309 institutions reported holding it in 13F filings for Q2 2026, worth $11.3B in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Praxis Precision Medicines, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 95
- −6 vs. Q1 2022
- Shares held
- 43.1M
- −2.24M (−4.9%) vs. Q1 2022
- Total value
- $105.5M
- −$357.7M (−77.2%) vs. Q1 2022
- New holders
- 21
- 38 more added
- Sold out
- 27
- 21 more reduced
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PRAX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 309 | $11.3B |
| Q1 2026 | 291 | $10.2B |
| Q4 2025 | 250 | $8.69B |
| Q3 2025 | 152 | $1.31B |
| Q2 2025 | 144 | $1.02B |
| Q1 2025 | 150 | $889.3M |
| Q4 2024 | 162 | $1.67B |
| Q3 2024 | 134 | $1.09B |
| Q2 2024 | 113 | $762.1M |
| Q1 2024 | 111 | $971.3M |
| Q4 2023 | 60 | $178.6M |
| Q3 2023 | 74 | $195.6M |
| Q2 2023 | 78 | $134.6M |
| Q1 2023 | 87 | $43.1M |
| Q4 2022 | 104 | $108.1M |
| Q3 2022 | 108 | $95.7M |
| Q2 2022 | 95 | $105.5M |
| Q1 2022 | 103 | $463.4M |
| Q4 2021 | 100 | $863.1M |
| Q3 2021 | 93 | $791.5M |
| Q2 2021 | 80 | $751.0M |
| Q1 2021 | 68 | $1.19B |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Praxis Precision Medicines, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Alps Advisors Inc | 0 | $0 | 0.00% | −46,747−100.0% | Sold out |
| Values First Advisors, Inc. | 0 | $0 | 0.00% | −45,990−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −28,048−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −20,300−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −19,433−100.0% | Sold out |
| Cna Financial Corp | 0 | $0 | 0.00% | −18,741−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −14,722−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −13,649−100.0% | Sold out |
| OneAscent Wealth Management LLC | 0 | $0 | 0.00% | −13,172−100.0% | Sold out |
| Voya Investment Management LLC | 0 | $0 | 0.00% | −12,538−100.0% | Sold out |
| Veritable, L.P. | 0 | $0 | 0.00% | −11,908−100.0% | Sold out |
| Prospera Financial Services Inc | 0 | $0 | 0.00% | −11,669−100.0% | Sold out |
| Bradley Foster & Sargent Inc | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −10,955−100.0% | Sold out |
| OneAscent Financial Services LLC | 0 | $0 | 0.00% | −10,557−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −8,515−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −4,370−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −2,443−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −1,284−100.0% | Sold out |
| Kayne Anderson Rudnick Investment Management LLC | 0 | $0 | 0.00% | −79−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −62−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −37−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | – | – | – | – | Not filed |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |